Pay in 4 interest-free payments of $10.00 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
administration of the compound at 10 mg/kg (three times a week for 6 consecutive weeks) contributed therapeutic benefits that were similar to repeat i
The Antifibrosis Effects of Peroxisome Proliferator-Activated Receptor δ on Rat Corneal Wound Healing after Excimer Laser Keratectomy
Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
195514-63-7
At the opposite
SB-334867 (base) - an orexin antagonist. CAS# 792173-99-0 Catalog No.:M7114-10 administration of the compound atSB 334867, an orexin antagonist, CAS No. 792173 99 0, is an orexin antagonist. SB 334867 was the first non peptide antagonist developed that is selective for the orexin receptor subtype OX1, with around 50x selectivity for OX1 over OX2 receptors. It has been shown to produce sedative and anorectic effects in animals, and has been useful in characterising the orexinergic regulation of brain systems involved with appetite and sleep, as well as other
US$ 110.00
US$ 40.00
US$ 39.00
US$ 87.00
US$ 30.00